Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
12/2007
12/06/2007US20070281952 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists
12/06/2007US20070281369 Acousto-Mechanical Detection Systems and Methods of Use
12/06/2007CA2651659A1 Lysine related derivatives as hiv aspartyl protease inhibitors
12/05/2007EP1863109A2 Solvents and new electrolytic compositions possessing a wide stability domain and high conductivity
12/05/2007EP1862452A1 Molten salt composition and use thereof
12/05/2007EP1862444A2 Ether compounds, compositions, and uses thereof
12/05/2007EP1861384A1 11-beta-hydroxysteroid dehydrogenase inhibitors
12/05/2007EP1861359A1 N-(n-sulfonylaminomethyl)cyclopropanecarboxamide derivatives useful for the treatment of pain
12/05/2007EP1861358A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist, and pharmaceutical compositions containing the same
12/05/2007EP1861357A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
12/05/2007CN101084178A (benzyloxy-biphenyl) acetic acids and derivatives thereof
12/04/2007US7303852 Resolution; sensitivity; heat stability and shelf stability
12/04/2007CA2193097C Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides
11/2007
11/29/2007WO2007135080A2 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them
11/29/2007WO2007134971A1 Benzoyl-substituted alanines
11/29/2007WO2007120647A3 Compositions useful as inhibitors of voltage-gated sodium channels
11/29/2007WO2007045893A3 Beta adrenergic receptor pharmacophore
11/29/2007CA2649794A1 (2r)-2-[(4-sulfonyl)aminophenyl] propanamides and pharmaceutical compositions containing them
11/28/2007EP1859798A1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
11/28/2007EP1858865A1 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
11/28/2007EP1858840A2 Analogs of 4-hydroxyisoleucine and uses thereof
11/28/2007CN100351244C Bis-aromatic alkanols
11/28/2007CN100351243C Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007CA2379695C Compounds for modulating the rage receptor
11/27/2007CA2299710C Aryloxyaniline derivatives
11/22/2007WO2007131996A1 Meta-xylylenediamine vanadate salts
11/21/2007EP1857440A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
11/21/2007EP1856031A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
11/21/2007EP1699756A4 Synthesis of ionic liquids
11/21/2007EP1692100A4 Method of preparing optically pure phenethylamine derivatives
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/21/2007CN101074207A Soluble chiral diamino derivative, its production and use
11/21/2007CN100349856C Propionic acid derivatives and their use as hPPARs activators
11/20/2007US7297816 2-(Benzo[1,2,5]thiadiazole-4-sulfonylamino)-4-chloro-N-methyl-N-(2-pyridin-2-yl-ethyl)-benzamide hydrochloride; cholecystokinin (CCK) receptor ligand inhibitors
11/20/2007US7297793 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/20/2007CA2206362C Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/15/2007WO2007056469A3 Certain chemical entities, compositions, and methods
11/15/2007US20070265426 Prepared by reacting a polyphosphonitrile with an amine or an alkali metal salt of an alcohol and an a perfluoroalkylsulfonylaminosulfonyl-substituted aniline or phenol salt; fuel cell membran materials
11/15/2007US20070265303 5-[(1R)-2-({2-[4-(4-{3-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-hydroxyphenyl}butoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one; chronic obstructive pulmonary disease (COPD), allergies
11/15/2007US20070264262 Adrenoceptor beta 2-mediated diseases such as asthma and chronic obstructive pulmonary disease (COPD); N-(4-tert-butylbenzyl)-4-{[({3-[(2R)-2-(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl) phenyl]ethyl}amino)propyl]phenyl}acetyl)amino]methy} benzamide
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007CA2248304C Surface modified carbonate materials
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/13/2007CA2157859C Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
11/13/2007CA2157856C Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/08/2007WO2007126262A1 Anion receptor, and electrolyte using the same
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007125196A1 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents
11/08/2007WO2006095263A8 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
11/08/2007US20070259951 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-[(3-methyl-4'-trifluoromethyl)-4-biphenylyl]methanesulfonamide
11/08/2007US20070259776 Preparation of Mono-N-sulphonylated diamines
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007CA2650480A1 Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents
11/07/2007EP1852422A2 Nitrosated and nitorsylated alpha-andrenergic receptor antagonist compounds, compositions and their uses
11/07/2007EP1851193A1 Hiv protease inhibitors
11/07/2007EP1850857A2 Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostate hyperplasia, prostate carcinoma, and spinobulbar muscular atrophy
11/07/2007EP1699755A4 Process for preparing fluorochemical monoisocyanates
11/07/2007EP1359141B1 Method of friedel-crafts acylation of anilides
11/07/2007CN101068776A Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101066983A Synthesis of metal bis-triflimide compounds and methods for purification thereof
11/07/2007CN101066943A Synthesis process of 2,4-dichloro-5-sulfonyl benzoic acid
11/07/2007CN100347151C Novel aminobenzoephenones
11/06/2007US7291634 N-substituted-benzyl-N-(hydroxyaminocarbonylmethyl)cycloalkyl(alk)oxybenzenesulfonamides, e.g., 2-[(cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-1-yl-benzyl)-amino]-N-hydroxy-acetamide; treating diseases mediated by matrix-degrading metalloproteinases, in particular hyperproliferative diseases
11/06/2007US7291620 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease
11/01/2007US20070255056 Method for manufacture of compounds related to the class of substituted sulfonyl urea anti-diabetics
11/01/2007US20070254916 Aryl and heteroaryl compounds, compositions, and methods of use
10/2007
10/31/2007EP1849760A1 Ether compounds, compositions, and uses thereof
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1246795B1 Antibacterial agents
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/31/2007CN101065353A Novel 2-cyano-3-(halo)alkoxy-benzenesulfonamide compounds for combating animal pests
10/31/2007CN101065352A Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
10/31/2007CN101062909A HIV-1prolease peptide mimic new inhibitor having biological activity, preparation method and usage
10/30/2007US7288571 Thyroid receptor ligands and method II
10/30/2007US7288567 Inhibitors of histone deacetylase
10/30/2007US7288554 For agriculture crops
10/25/2007WO2007120647A2 Compositions useful as inhibitors of voltage-gated sodium channels
10/25/2007WO2007120012A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
10/25/2007WO2007119110A2 Process for the preparation of tamsulosin and related compounds
10/25/2007WO2007118964A1 Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof
10/25/2007WO2007118852A1 Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists
10/25/2007WO2007118817A1 Coupling compounds and hair dyeing compositions containing them
10/25/2007WO2007098030A8 Selective n-sulfonylation of 2-amino trifluoroalkyl substituted alcohols
10/25/2007WO2007088276A3 Sulfonamide derivatives, preparation and therapeutic application thereof
10/25/2007US20070249832 For agriculture crops
10/25/2007US20070249682 Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications
10/25/2007US20070245810 Detection Cartridges, Modules, Systems and Methods
10/25/2007CA2648202A1 Compositions useful as inhibitors of voltage-gated sodium channels
10/25/2007CA2627133A1 Process for the preparation of tamsulosin and related compounds
10/24/2007EP1847528A1 Coupling compounds and hair dyeing compositions containing them
10/24/2007EP1534671A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/24/2007EP1287006B1 Antitumoral compounds
10/24/2007CN101061116A Sulfonamide compounds
10/24/2007CN101058549A 4-methoxy-1,3-phenyl disubstituted amide derivative
10/24/2007CN100344612C Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation
10/24/2007CN100344611C 4-nitro-2-[(4'-methoxyl)-phenoxy]-toluenesulfonamide derivant and its medical uses
10/23/2007US7285680 β-alanine derivatives and the use thereof
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 177